How dangerous are India’s generic drugs? Very


India relies on the weak oversight of developing countries that make up the bulk of its exports – that’s how it can continue to push substandard and often deadly medicines there. — Bloomberg

FOR a nation that seeks to claim the mantle of “pharmacy to the world,” India is scandalously short on regulatory oversight.

In the last six months, its generic cough syrups have killed dozens of children, its eye drops have caused blindness and its chemotherapy drugs have been contaminated.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
India , genericdrugs , regulation , oversight , scandals

Next In Business News

Ancom Nylex reports higher 2Q net profit
One Gasmaster IPO oversubscribed 25.24 times ahead of ACE Market debut
Broad-based selling drags FBM KLCI below 1,700 for third straight day
Dollar extends losses as geopolitics revive 'Sell America' trade
Oil prices waver while investors eye Greenland developments
Gold scales new high past US$4,700/oz as Trump threats fuel safe-haven demand
EcoFirst appoints two new independent non-executive directors
Indonesia to ensure�c.bank independence, rupiah to rebound, finance minister says
Standard Chartered sees Malaysia’s 2026 GDP growth at 4.5%
Asian bonds draw strong foreign inflows in December

Others Also Read